Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Nam Y, Koo H, Yang Y, Shin S, Zhu Z, Kim D, Cho HJ, Mu Q, Choi SW, Sa JK, Seo YJ, Kim Y, Lee K, Oh JW, Kwon YJ, Park WY, Kong DS, Seol HJ, Lee JI, Park CK, Lee HW, Yoon Y, Wang J.
Nam Y, et al. Among authors: seol hj.
Genome Med. 2023 Mar 13;15(1):16. doi: 10.1186/s13073-023-01165-8.
Genome Med. 2023.
PMID: 36915208
Free PMC article.